Carlie Thompson, MD
Accepting new patients

Carlie Thompson, MD

  • Breast Surgery
Revlon Breast Center | 100 Medical Plaza, Suite 310, Los Angeles, CA 90095

About

Dr. Carlie Thompson is a board-certified and fellowship-trained breast surgical oncologist and an Assistant Professor of Surgery. She uses a multidisciplinary approach to expertly manage breast cancer, benign breast disease and high risk women. Her clinical interests include using advanced surgical techniques, such as nipple-sparing mastectomy, nipple delay, aesthetic flat closure and targeted axillary dissection, treating young women with breast cancer and improving the quality of the lives of patients before, during and after breast cancer treatment. Dr. Thompson is a compassionate provider who cares deeply for her patients and their families.

Dr. Thompson obtained her medical degree from Washington University in St. Louis, where she was elected into Alpha Omega Alpha honor society. She received her surgery training at Northwestern University and the University of California, San Francisco, during which she received several awards for teaching and the prestigious Chesson Award for Compassion in Surgery. She completed a breast surgical oncology fellowship at Cedars-Sinai Medical Center in Los Angeles. 

Dr. Thompson has well over a decade of experience performing scientific and medical research and has won several awards for her work. She has authored many peer-reviewed articles and book chapters and has presented at a variety of national meetings. Her research interests include breast cancer screening, management of DCIS, and the neoadjuvant treatment of breast cancer.

Dr. Thompson is a member of the Equity, Diversity and Inclusion Committee and the Quality Improvement Committee for the UCLA Department of Surgery, and she is an active member of the American College of Surgeons, the Association of Women Surgeons, the Society of Surgical Oncology and the American Society of Breast Surgeons.

Languages

English

Education

Medical Board Certification

Surgery, American Board of Surgery, 2017

Fellowship

Breast Surgical Oncology, Cedars-Sinai Medical Center, 2018

Residencies

General Surgery, UCSF Department of Surgery, 2017
General Surgery, Northwestern University Department of Surgery, 2013

Internship

General Surgery, Northwestern University Department of Surgery, 2011

Degree

MD, Washington University School of Medicine in St. Louis, 2010

Recognitions

Locations

San Fernando Valley

Burbank Breast Care

Breast Medical Oncology| Breast Surgery| Breast Surgical Oncology
San Fernando Valley

Encino Surgery

General Surgery| Plastic Surgery| Endocrine Surgery +3 more specialties

Hospital Affiliations

Ronald Reagan UCLA Medical Center

UCLA Santa Monica Medical Center

Videos

Maricia Finds Community in UCLA Health's AYA Cancer Program

Research

Interests

Breast cancer screening, management of DCIS, and the neoadjuvant treatment of breast cancer.

Publications

  1. Ye L, Rünger D, Angarita SA, Hadaya J, Baker JL, Lee MK, Thompson CK, Attai DJ, DiNome ML. Higher risk tumor features are not associated with higher nodal stage in patients with estrogen receptor-positive, node-positive breast cancer. Breast Cancer Res Treat. 2022 Jun;193(2):429-436. doi: 10.1007/s10549-022-06581-9. Epub 2022 Apr 7. PMID: 35389189
  2. Baker JL, Haji F, Kusske AM, Fischer CP, Hoyt AC, Thompson CK, Lee MK, Attai D, DiNome ML. SAVI SCOUT® localization of metastatic axillary lymph node prior to neoadjuvant chemotherapy for targeted axillary dissection: a pilot study. Breast Cancer Res Treat. 2022 Jan;191(1):107-114. doi: 10.1007/s10549-021-06416-z. Epub 2021 Oct 15. PMID: 34652548.
  3. Baker JL, Dizon DS, Streja E, Wenziger CM, Thompson CK, Lee MK, DiNome ML, Attai DJ. Going flat after mastectomy: patient reported outcomes by online survey. Ann Surg Oncol. 2021 May;28(5):2493-2505.
  4. Mandelbaum AD, Thompson CK, Attai DJ, Baker JL, Slack G, DiNome ML, Benharash P, Lee MK. National Trends in Immediate Breast Reconstruction: An Analysis of Implant-Based Versus Autologous Reconstruction After Mastectomy. Ann Surg Oncol. 2020 Nov;27(12):4777-4785. doi: 10.1245/s10434-020-08903-x. Epub 2020 Jul 25. PMID: 32712889.
  5. Angarita S, Ye L, Rünger D, Hadaya J, Baker JL, Dawson N, Thompson CK, Lee MK, Attai DJ, DiNome ML. Assessing the Burden of Nodal Disease for Breast Cancer Patients with Clinically Positive Nodes: Hope for More Limited Axillary Surgery. Ann Surg Oncol. 2021 May;28(5):2609-2618. doi: 10.1245/s10434-020-09228-5. Epub 2020 Oct 21. PMID: 33084993.
  6. Baker JL, Hegde J, Thompson CK, Lee MK, DiNome ML. Locoregional management of inflammatory breast cancer. Curr Breast Cancer Rep, in press.
  7. Mandelbaum A, Nakhla M, Seo YJ, Dobaria V, Attai DJ, Baker JL, Thompson CK, DiNome ML, Benharash P, Lee MK. National trends and predictors of mastectomy with immediate breast reconstruction. Am J Surg. 2021 Oct;222(4):773-779. doi: 10.1016/j.amjsurg.2021.02.014. Epub 2021 Feb 17. PMID: 33627231.
  8. Berkowitz MJ, Thompson CK, Zibecchi LT, Lee MK, Streja E, Berkowitz JS, Wenziger CM, Baker JL, DiNome ML, Attai DJ. How patients experience endocrine therapy for breast cancer: an online survey of side effects, adherence, and medical team support. J Cancer Surviv. 2021 Feb;15(1):29-39. doi: 10.1007/s11764-020-00908-5. Epub 2020 Aug 17. PMID: 32804353; PMCID: PMC7430212.
  9. Thompson CK, Lee MK, Baker JL, Attai DJ, DiNome ML. Taking a Second Look at Neoadjuvant Endocrine Therapy for the Treatment of Early Stage Estrogen Receptor Positive Breast Cancer During the COVID-19 Outbreak. Ann Surg. 2020 Aug;272(2):e96-e97. doi: 10.1097/SLA.0000000000004027. PMID: 32675509; PMCID: PMC7268854.
  10. Lee MK, Sanaiha Y, Kusske AM, Thompson CK, Attai DJ, Baker JL, Fischer CP, DiNome ML. A comparison of two non-radioactive alternatives to wire for the localization of non-palpable breast cancers. Breast Cancer Res Treat. 2020 Jul;182(2):299-303. doi: 10.1007/s10549-020-05707-1. Epub 2020 May 25. PMID: 32451679.
  11. Lindström LS, Yau C, Czene K, Thompson CK, Hoadley KA, Van't Veer LJ, Balassanian R, Bishop JW, Carpenter PM, Chen YY, Datnow B, Hasteh F, Krings G, Lin F, Zhang Y, Nordenskjöld B, Stål O, Benz CC, Fornander T, Borowsky AD, Esserman LJ; STO Trialists Group. Intratumor Heterogeneity of the Estrogen Receptor and the Long-term Risk of Fatal Breast Cancer. J Natl Cancer Inst. 2018 Jul 1;110(7):726-733. doi: 10.1093/jnci/djx270. PMID: 29361175; PMCID: PMC6037086.
  12. Esserman LJ, Yau C, Thompson CK, van’t Veer LJ, Borowsky AD, Hoadley KA, Tobin NP, Nordenskjold B, Forander T, Stal O, Benz CC, Lindstrom LS. Use of molecular tools to identify patients with indolent breast cancers with ultralow risk over 2 decades. JAMA Oncol. 2017 Nov 1;3(11):1503-1510.
  13. Esserman LJ, Anton-Culver H, Borowsky A, Brain S, Cink T, Crawford B, Eklund M, Esserman L, Fenton J, Heditsian D, Hiatt RA, Hogarth M, Kaplan C, Koenig B, LaCroix A, Larsen KM, Lee V, Matthews J, Madlensky L, Naeim A, Ojeda-Fournier H, Parker BA, Sepucha K, Shieh Y, Stover Fiscalini A, Thompson C, Tice J, Van 't Veer L, Wenger N, Ziv E. The WISDOM Study: breaking the deadlock in the breast cancer screening debate. NPJ Breast Cancer. 2017 Sept 13;3:34.
  14. Shieh Y, Eklund M, Madlensky L, Sawyer SD, Thompson CK, Stover Fiscalini A, Ziv E, Van't Veer LJ, Esserman LJ, Tice JA; Athena Breast Health Network Investigators. Breast Cancer Screening in the Precision Medicine Era: Risk-Based Screening in a Population-Based Trial. J Natl Cancer Inst. 2017 Jan 27;109(5). doi: 10.1093/jnci/djw290. PMID: 28130475.
  15. Thompson CK, Eklund M, Esserman LJ. Putting the “Great Mammography Debate” to rest. Am J Hematol Oncol. 2015 Sep;11(9):21-2.

Recognitions

  • Top Doctors, Pasadena Magazine, 2023
  • Top Doctors, Los Angeles Magazine, 2022, 2023
  • Chesson Award for Compassion in Surgery
  • Lynn Sage Scholar
  • Association of Women Surgeons Outstanding Mentorship Award
  • Alpha Omega Alpha